Literature DB >> 33659227

Stillbirths, Neonatal Morbidity, and Mortality in Health-Facility Deliveries in Urban Gambia.

Bully Camara1, Claire Oluwalana1, Reiko Miyahara2, Alyson Lush1, Beate Kampmann1, Kebba Manneh3, Uduak Okomo1, Umberto D'Alessandro1, Anna Roca1.   

Abstract

Background: The Gambia Demographic and Health Survey 2013 data showed that up to 63% of deliveries in the country occur in health facilities. Despite such a high rate, there are few facility-based studies on delivery outcomes in the country. This analysis ancillary to a randomized control trial describes occurrence of poor pregnancy outcomes in a cohort of women and their infants delivering in a government health facility in urban Gambia.
Methods: Using clinical information obtained during the trial, we calculated rates of poor pregnancy outcomes including stillbirths, hospitalization and neonatal deaths. Logistic regression was used to calculate odds ratio (OR) and 95% confidence interval (CI) in the risk factors analysis.
Results: Between April 2013 and 2014, 829 mothers delivered 843 babies, including 13 stillbirths [15.4 (7.1-23.8)] per 1,000 births. Among 830 live born infants, 7.6% (n = 63) required hospitalization during the 8-week follow-up period. Most of these hospitalizations (74.6%) occurred during the early neonatal period (<7 days of life). Severe clinical infections (i.e., sepsis, meningitis and pneumonia) (n = 27) were the most common diagnoses, followed by birth asphyxia (n = 13), major congenital malformations (n = 10), jaundice (n = 6) and low birth weight (n = 5). There were sixteen neonatal deaths, most of which also occurred during the early neonatal period. Overall, neonatal mortality rate (NMR) and perinatal mortality rate (PMR) were 19.3 (CI: 9.9-28.7) per 1,000 live births and 26.1 (CI: 15.3-36.9) per 1,000 total births, respectively. Severe clinical infections and birth asphyxia accounted for 37 and 31% of neonatal deaths, respectively. The risk of hospitalization was higher among neonates with severe congenital malformations, low birth weight, twin deliveries, and those born by cesarean section. Risk of mortality was higher among neonates with severe congenital malformations and twin deliveries.
Conclusion: Neonatal hospitalization and deaths in our cohort were high. Although vertical interventions may reduce specific causes of morbidity and mortality, data indicate the need for a holistic approach to significantly improve the rates of poor pregnancy outcomes. Critically, a focus on decreasing the high rate of stillbirths is warranted. Clinical Trial Registration: ClinicalTrials.gov Identifier: NCT01800942.
Copyright © 2021 Camara, Oluwalana, Miyahara, Lush, Kampmann, Manneh, Okomo, D'Alessandro and Roca.

Entities:  

Keywords:  The Gambia; birth asphyxia; congenital malformation; hospitalization; neonatal mortality; sepsis; stillbirth

Year:  2021        PMID: 33659227      PMCID: PMC7917219          DOI: 10.3389/fped.2021.579922

Source DB:  PubMed          Journal:  Front Pediatr        ISSN: 2296-2360            Impact factor:   3.418


  26 in total

1.  Stillbirths in rural hospitals in the gambia: a cross-sectional retrospective study.

Authors:  Abdou Jammeh; Siri Vangen; Johanne Sundby
Journal:  Obstet Gynecol Int       Date:  2010-06-30

2.  Contribution of congenital malformations to perinatal mortality. A 10 years prospective regional study in The Netherlands.

Authors:  A E De Galan-Roosen; J C Kuijpers; A P Meershoek; D van Velzen
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1998-09       Impact factor: 2.435

Review 3.  Ending preventable maternal and newborn mortality and stillbirths.

Authors:  Doris Chou; Bernadette Daelmans; R Rima Jolivet; Mary Kinney; Lale Say
Journal:  BMJ       Date:  2015-09-14

4.  Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors: 
Journal:  Lancet       Date:  2014-12-18       Impact factor: 79.321

5.  How many births in sub-Saharan Africa and South Asia will not be attended by a skilled birth attendant between 2011 and 2015?

Authors:  Sonya Crowe; Martin Utley; Anthony Costello; Christina Pagel
Journal:  BMC Pregnancy Childbirth       Date:  2012-01-17       Impact factor: 3.007

6.  Consanguinity and reproductive health among Arabs.

Authors:  Ghazi O Tadmouri; Pratibha Nair; Tasneem Obeid; Mahmoud T Al Ali; Najib Al Khaja; Hanan A Hamamy
Journal:  Reprod Health       Date:  2009-10-08       Impact factor: 3.223

7.  Avoiding 40% of the premature deaths in each country, 2010-30: review of national mortality trends to help quantify the UN sustainable development goal for health.

Authors:  Ole F Norheim; Prabhat Jha; Kesetebirhan Admasu; Tore Godal; Ryan J Hum; Margaret E Kruk; Octavio Gómez-Dantés; Colin D Mathers; Hongchao Pan; Jaime Sepúlveda; Wilson Suraweera; Stéphane Verguet; Addis T Woldemariam; Gavin Yamey; Dean T Jamison; Richard Peto
Journal:  Lancet       Date:  2014-09-18       Impact factor: 79.321

8.  Prevention of bacterial infections in the newborn by pre-delivery administration of azithromycin: Study protocol of a randomized efficacy trial.

Authors:  Anna Roca; Claire Oluwalana; Bully Camara; Abdoulie Bojang; Sarah Burr; Timothy M E Davis; Robin Bailey; Beate Kampmann; Jenny Mueller; Christian Bottomley; Umberto D'Alessandro
Journal:  BMC Pregnancy Childbirth       Date:  2015-11-19       Impact factor: 3.007

9.  Beyond newborn survival: the world you are born into determines your risk of disability-free survival.

Authors:  Joy E Lawn; Hannah Blencowe; Gary L Darmstadt; Zulfiqar A Bhutta
Journal:  Pediatr Res       Date:  2013-11-15       Impact factor: 3.756

10.  Oral azithromycin given during labour decreases bacterial carriage in the mothers and their offspring: a double-blind randomized trial.

Authors:  A Roca; C Oluwalana; A Bojang; B Camara; B Kampmann; R Bailey; A Demba; C Bottomley; U D'Alessandro
Journal:  Clin Microbiol Infect       Date:  2016-03-26       Impact factor: 8.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.